G. Krebbers BEng publications

foto

Publications BEng G. Krebbers

Position
Support Staff
Main activities
Research
Specialisation
Exp. Dermatology Vitiligo/Melanoma
Focus of research

Exp. Dermatology - Vitiligo/Melanoma

2020

  • de Boer Onno J., Krebbers Gabrielle, Mackaaij Claire, Florquin Sandrine, de Rie Menno A., van der Wal Allard C., Teunissen Marcel B. M. Authors’ Response to Letter to the Editor on “Unidentified Variables May Account for Variability in Multiplexing Results” journal of histochemistry and cytochemistry 2020;68 (5):355-356 [PubMed]
  • de Boer Onno J., Krebbers Gabrielle, Mackaaij Claire, Florquin Sandrine, de Rie Menno A., van der Wal Allard C., Teunissen Marcel B. M. Comparison of Two Different Immunohistochemical Quadruple Staining Approaches to Identify Innate Lymphoid Cells in Formalin-fixed Paraffin-embedded Human Tissue journal of histochemistry and cytochemistry 2020;68 (2):127-138 [PubMed]
  • Tio Darryl, Willemsen Marcella, Krebbers Gabrielle, Kasiem Fazira R., Hoekzema Rick, van Doorn Remco, Bekkenk Marcel W., Luiten Rosalie M. Differential Expression of Cancer Testis Antigens on Lentigo Maligna and Lentigo Maligna Melanoma American Journal of dermatopathology 2020;42 (8):625-627 [PubMed]

2018

  • Teulings Hansje-Eva, Tjin Esther P. M., Willemsen Karina J., van der Kleij Stephanie, Meulen Sylvia ter, Kemp E. Helen, Krebbers Gabrielle, van Noesel Carel J. M., Franken Cornelis L. M. C., Drijfhout Jan W., Melief Cornelis J. M., Nieuweboer-Krobotova Ludmila, Nieweg Omgo E., van der Hage Jos A., van der Veen J. P. Wietze, Relyveld Germaine N., Luiten Rosalie M. Anti-Melanoma immunity and local regression of cutaneous metastases in melanoma patients treated with monobenzone and imiquimod; a phase 2 a trial Oncoimmunology 2018;7 (4) [PubMed]

2015

  • Komen Lisa, Vrijman Charlotte, Tjin Esther P. M., Krebbers Gabrielle, de Rie Menno A., Luiten Rosalie M., van der Veen J. P. Wietze, Wolkerstorfer Albert Autologous cell suspension transplantation using a cell extraction device in segmental vitiligo and piebaldism patients: A randomized controlled pilot study Journal of the American Academy of Dermatology 2015;73 (1):170-172 [PubMed]

2014

  • Tjin Esther P. M., Krebbers Gabrielle, Meijlink Kimberley J., van de Kasteele Willeke, Rosenberg Efraim H., Sanders Joyce, Nederlof Petra M., van de Wiel Bart A., Haanen John B. A. G., Melief Cornelis J. M., Vyth-Dreese Florry A., Luiten Rosalie M. Immune-escape markers in relation to clinical outcome of advanced melanoma patients following immunotherapy Cancer immunology research 2014;2 (6):538-546 [PubMed]
  • Teulings Hansje-Eva, Willemsen Karin J., Glykofridis Iris, Krebbers Gabrielle, Komen Lisa, Kroon Marije W., Kemp E. Helen, Wolkerstorfer Albert, van der Veen J. P. Wietze, Luiten Rosalie M., Tjin Esther P. M. The antibody response against MART-1 differs in patients with melanoma-associated leucoderma and vitiligo Pigment cell & melanoma research 2014;27 (6):1086-1096 [PubMed]

2013

  • Kroon M. W., Kemp E. Helen, Wind B. S., Krebbers G., Bos J. D., Gawkrodger D. J., Wolkerstorfer A., van der Veen J. P. Wietze, Luiten R. M. Melanocyte antigen-specific antibodies cannot be used as markers for recent disease activity in patients with vitiligo Journal of the European Academy of Dermatology and Venereology 2013;27 (9):1172-1175 [PubMed]
  • Teulings H. E., Tjin E. P. M., Willemsen K. J., Krebbers G., van Noesel C. J., Kemp E. H., Nieuweboer-Krobotova L., van der Veen J. P. W., Luiten R. M. Radiation-induced melanoma-associated leucoderma, systemic antimelanoma immunity and disease-free survival in a patient with advanced-stage melanoma: a case report and immunological analysis British journal of dermatology 2013;168 (4):733-738 [PubMed]

2011

  • Tjin Esther P. M., Konijnenberg Debby, Krebbers Gabrielle, Mallo Henk, Drijfhout Jan W., Franken Kees L. M. C., van der Horst Chantal M. A. M., Bos Jan D., Nieweg Omgo E., Kroon Bin B. R., Haanen John B. A. G., Melief Cornelis J. M., Vyth-Dreese Florry A., Luiten Rosalie M. T-cell immune function in tumor, skin, and peripheral blood of advanced stage melanoma patients: implications for immunotherapy Clinical cancer research 2011;17 (17):5736-5747 [PubMed]